These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35624589)

  • 21. Assessment of factors associated with improved glycemic control after switching from intermittently scanned to real-time continuous glucose monitoring in Japanese patients with type 1 diabetes.
    Yamada E; Nakajima Y; Horiguchi K; Okada S; Yamada M
    Endocr J; 2023 Dec; 70(12):1187-1193. PubMed ID: 37766568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Glucose Management Indicator: Time to Change Course?
    Selvin E
    Diabetes Care; 2024 Jun; 47(6):906-914. PubMed ID: 38295402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous Glucose Monitoring Metrics and Hemoglobin A1c Relationship in Patients with Type 2 Diabetes Treated by Hemodialysis.
    Galindo RJ; Moazzami B; Tuttle KR; Bergenstal RM; Peng L; Umpierrez GE
    Diabetes Technol Ther; 2024 Nov; 26(11):862-868. PubMed ID: 38805310
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of the Glucose Management Indicator Using Different Sampling Durations.
    Bailey R; Calhoun P; Bergenstal RM; Beck RW
    Diabetes Technol Ther; 2023 Feb; 25(2):148-150. PubMed ID: 36130138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early Initiation of Intermittently Scanned Continuous Glucose Monitoring in a Pediatric Population With Type 1 Diabetes: A Real World Study.
    Franceschi R; Cauvin V; Stefani L; Berchielli F; Soffiati M; Maines E
    Front Endocrinol (Lausanne); 2022; 13():907517. PubMed ID: 35784525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of continuous glucose monitoring-derived person-specific HbA1c in the presence and absence of complications in type 1 diabetes.
    Xu Y; Oriot P; Dunn TC; Hermans MP; Ram Y; Cheng A; Ajjan RA
    Diabetes Obes Metab; 2022 Dec; 24(12):2383-2390. PubMed ID: 35876223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Personal Glycation Factors and Calculated Hemoglobin A1c for Diabetes Management: Real-World Data from the Diabetes Prospective Follow-up (DPV) Registry.
    Xu Y; Grimsmann JM; Karges B; Hofer S; Danne T; Holl RW; Ajjan RA; Dunn TC
    Diabetes Technol Ther; 2021 Jun; 23(6):452-459. PubMed ID: 33395370
    [No Abstract]   [Full Text] [Related]  

  • 28. Novel Glycemic Index Based on Continuous Glucose Monitoring to Predict Poor Clinical Outcomes in Critically Ill Patients: A Pilot Study.
    Ha EY; Chung SM; Park IR; Lee YY; Choi EY; Moon JS
    Front Endocrinol (Lausanne); 2022; 13():869451. PubMed ID: 35600594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM-Japan study.
    Sakane N; Hirota Y; Yamamoto A; Miura J; Takaike H; Hoshina S; Toyoda M; Saito N; Hosoda K; Matsubara M; Tone A; Kawashima S; Sawaki H; Matsuda T; Domichi M; Suganuma A; Sakane S; Murata T
    J Diabetes Investig; 2023 Apr; 14(4):582-590. PubMed ID: 36789495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of obesity on blood glucose control using continuous glucose monitoring data among patients with type 1 diabetes.
    Nicolau J; Romano A; Rodríguez I; Sanchís P; Puga M; Masmiquel L
    Endocrinol Diabetes Nutr (Engl Ed); 2024 May; 71(5):202-207. PubMed ID: 38897703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the relationship between glycated hemoglobin A1c and mean glucose levels derived from the professional continuous flash glucose monitoring system.
    Yamada M; Okada S; Oda H; Nakajima Y; C Bastie C; Kasai Y; Osaki A; Shimoda Y; Shibusawa R; Uehara R; Saito T; Ozawa A; Yamada E
    Endocr J; 2020 May; 67(5):531-536. PubMed ID: 32023560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term glucose-lowering effect of intermittently scanned continuous glucose monitoring for type 1 diabetes patients in poor glycaemic control from Region North Denmark: An observational real-world cohort study.
    Jensen MH; Cichosz SL; Gustenhoff P; Nikontovic A; Hejlesen O; Vestergaard P
    PLoS One; 2022; 17(10):e0274626. PubMed ID: 36240184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the inter-subject variability in the relationship between glucose monitoring metrics and glycated hemoglobin for pediatric patients with type 1 diabetes.
    Bosoni P; Calcaterra V; Tibollo V; Malovini A; Zuccotti G; Mameli C; Sacchi L; Bellazzi R; Larizza C
    J Pediatr Endocrinol Metab; 2021 May; 34(5):619-625. PubMed ID: 33823102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age and Red Blood Cell Parameters Mainly Explain the Differences Between HbA1c and Glycemic Management Indicator Among Patients With Type 1 Diabetes Using Intermittent Continuous Glucose Monitoring.
    Azcoitia P; Rodríguez-Castellano R; Saavedra P; Alberiche MP; Marrero D; Wägner AM; Ojeda A; Boronat M
    J Diabetes Sci Technol; 2024 Nov; 18(6):1370-1376. PubMed ID: 37568271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Relationship Between CGM-Derived Metrics, A1C, and Risk of Hypoglycemia in Older Adults With Type 1 Diabetes.
    Toschi E; Slyne C; Sifre K; O'Donnell R; Greenberg J; Atakov-Castillo A; Carl S; Munshi M
    Diabetes Care; 2020 Oct; 43(10):2349-2354. PubMed ID: 32461211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Hemoglobin A1c before and after initiation of continuous glucose monitoring in children with type 1 diabetes mellitus.
    Gurnurkar S; Owens L; Chalise S; Vyas N
    J Pediatr Endocrinol Metab; 2021 Mar; 34(3):311-317. PubMed ID: 33618445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HbA1c overestimates the glucose management indicator: a pilot study in patients with diabetes, chronic kidney disease not on dialysis, and anemia using isCGM.
    Gómez Medina A; González CA; Muñoz OM; Gómez Y; Jaramillo PE; Henao D; Rodríguez LM; Molina Y
    Ther Adv Endocrinol Metab; 2024; 15():20420188241252546. PubMed ID: 38827386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world glycaemic outcomes in adult persons with type 1 diabetes using a real-time continuous glucose monitor compared to an intermittently scanned glucose monitor: A retrospective observational study from the Canadian LMC diabetes registry (REAL-CGM-T1D).
    Brown RE; Chu L; Norman GJ; Abitbol A
    Diabet Med; 2022 Nov; 39(11):e14937. PubMed ID: 36065977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accurate prediction of HbA1c by continuous glucose monitoring using a kinetic model with patient-specific parameters for red blood cell lifespan and glucose uptake.
    Xu Y; Hirota Y; Ajjan RA; Yamamoto A; Matsuoka A; Ogawa W; Dunn TC
    Diab Vasc Dis Res; 2021; 18(3):14791641211013734. PubMed ID: 33960242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.